Global Misoprostol Market Size, Share, and Trends Analysis Report, By Application (Gastric Ulcer, Duodenal Ulcer, Peptic Ulcer, Anti-Early Pregnancy, and Other) and By Distribution Channel (Offline and Online), Forecast (2022-2028)

The global misoprostol market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Misoprostol is used to prevent ulcers in people who take certain arthritis or pain medicines, including aspirin that can cause ulcers. It protects the stomach lining and decreases stomach acid secretion. The global misoprostol market is growing due to the rising prevalence of arthritis globally. According to the article published by the Centre for Disease Control and Prevention in November 2021, an estimation of 58.5 million people has doctor-diagnosed arthritis which accounts for 1 in every 4 adults in the US alone. The rise in different kinds of ulcers among individuals is also driving the growth of the market. According to an article by WebMD LLC, only peptic ulcer affects around 4.6 million people annually in the US alone and an estimation of 10% population in the US was diagnosed with a duodenal ulcer at some point in time. Additionally, the ulcer is more prevalent in older age. Therefore, the rise in the geriatric population is directly impacting the demand for misoprostol. Furthermore, this misoprostol drug is also prescribed by doctors to treat early pregnancy along with other medications, which is also anticipated to propel the growth of the global misoprostol market during the forecast period.

The North American region is anticipated to hold the major share in the global misoprostol market due to the larger presence of the geriatric population in this region. According to the US Department of Health and Human Services in May 2021, an estimation of 54.1 million geriatric populations is reported only in the US. Several other factors, including the rising prevalence of ulcer patients in this region, improved healthcare infrastructure along with the early adoption of advanced treatment in this region are also anticipated to drive the global misoprostol market in this region.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Cadila Pharmaceuticals, ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD., and PD-Rx Pharmaceuticals, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Misoprostol Market Report by Segment

By Application

• Gastric Ulcer
• Duodenal Ulcer
• Peptic Ulcer
• Anti-Early Pregnancy
• Other

By Distribution Channel

• Offline
• Online

Global Misoprostol Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa